CIRSE Congress 2025 - 24-month results show the Biotronik Dynetic-35 cobalt chromium balloon-expandable stent was safe and effective in iliac arteries.

Prof Marianne Brodmann (Medical University of Graz, Graz, AT) joins us to discuss 24-month findings from BIONETIC-I (NCT04830228). The prospective, international, multi-center, single-arm study aimed to investigate the safety and effectiveness of the Biotronik Dynetic-35 cobalt chromium balloon-expandable stent in association with the Passeo-35 Xeo peripheral dilation catheter for the treatment of peripheral artery disease and atherosclerotic disease in iliac arteries.

Interview Questions:
1. What is the reasoning behind the study?
2. Could you tell us about the unique features of the Biotronik Dynetic-35 stent?
3. What was the study design and patient population?
4. What were the key findings?
5. What are the take-home messages for practice?
6. What further research is needed in this area?

Recorded virtually from Graz, 2025.

Editors: Yazmin Sadik, Jordan Rance.
Videographers: Dan Brent.

Support: This is an independent interview produced by Radcliffe Vascular.